High cost, difficult to write off, low efficiency, channel rebate fees are withheld, unable to reach the terminal and consumers effectively
Counterfeit and shoddy harm consumersCounterfeit medicines seriously threaten the health of consumers, harm the income of pharmaceutical companies, and are extremely harmful to society
Diversified products, difficult to assign codesPharmaceutical business enterprises shall establish a drug traceability system in accordance with relevant national requirements to realize that the source of the drug can be checked, whereabouts can be traced, and responsibility can be investigated. Drug traceability should cover multiple links such as production, circulation and use.
National regulatory requirements are traceableRealize that the source of the drug can be investigated, whereabouts can be traced, and the responsibility can be investigated. It does not meet the requirements of the State Drug Administration. Drug traceability should cover multiple links such as production, circulation and use, and information technology is used to ensure drug safety.
Need to improve the level of digital managementThere are many pharmaceutical companies, small, scattered, and chaotic problems, poor production conditions, backward technology, outdated equipment, and the application of corporate digital codes lacks top-level design and planning, and cannot play the code function value.
Poor channel control capabilities, consumers can’t reachPoor management from channel to terminal, and the channels controlled by distribution data cannot effectively reach direct consumers.